Brian M. Johnson Net Worth

Mr. Brian M. Johnson biography

Brian M. Johnson is the Chief Commercial Officer at Novan Inc.

How old is Mr Johnson?

Mr Johnson is 55, he's been the Chief Commercial Officer of Novan Inc since . There are 8 older and 4 younger executives at Novan Inc. The oldest executive at Novan Inc is Robert Ingram, 77, who is the Independent Director.

What's Mr Johnson's mailing address?

Brian's mailing address filed with the SEC is C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE, NC, 27560.

Insiders trading at Novan Inc

Over the last 8 years, insiders at Novan Inc have traded over $72,487 worth of Novan Inc stock and bought 1,476,993 units worth $9,839,419 . The most active insiders traders include John W Palmour, Robert J Keegan, and Life Sciences Holdings Ltd .... On average, Novan Inc executives and independent directors trade stock every 70 days with the average trade being worth of $4,566. The most recent stock trade was executed by Machelle Sanders on 27 June 2023, trading 11,553 units of NOVN stock currently worth $4,737.

What does Novan Inc do?

novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.

Novan Inc executives and stock owners

Novan Inc executives and other stock owners filed with the SEC include:

• Paula Brown Stafford M.P.H.,
  Pres, CEO & Chairwoman
• Paula Brown Stafford,
  Pres, CEO & Chairwoman
• Paula Stafford,
  Chairman of the Board, President, Chief Executive Officer
• John M. Gay CPA,
  CFO & Corp. Sec.
• John M. Gay,
  CFO & Corp. Sec.
• John Gay,
  Chief Financial Officer, Vice President - Finance, Corporate Controller, Corporate Secretary
• Robert Ingram,
  Independent Director
• Jenene Thomas,
  Investors Relation
• Machelle Sanders,
  Independent Director
• John Palmour,
  Independent Director
• Robert Keegan,
  Independent Director
• James Bierman,
  Director
• W. Geer,
  Lead Independent Director
• Stanley Hollenbach BS, J.D.,
  Sr. VP of R&D
• John A. Donofrio Jr.,
  Exec. VP, COO & Pres of EPI Health
• Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D.,
  Chief Medical Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Elizabeth Messersmith,
  Sr. VP & Chief Devel. Officer
• Stanley Hollenbach BS,J.D.,
  Sr. VP of R&D
• Cole Ikkala,
  Director of Investor Relations, Communications & Bus. Devel.
• Dr. Carri Geer,
  Sr. VP & CTO
• Andrew J. Novak,
  VP of Accounting & Bus. Operations and Chief Accounting Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Life Sciences Holdings Ltd ...,
  
• Sean Murphy,
  Director
• Nathan Stasko,
  President & CSO, Director
• G. Kelly Martin,
  Chief Executive Officer
• William L Hodges,
  Interim Chief Financial Office
• M. Joyce Rico,
  Chief Medical Officer
• F Nealt.D.H. One, Llct.D.H....,
  
• A. Donofrio John,
  EVP, Chief Operating Officer
• Eugene Sun,
  Director
• Jeff N Hunter,
  EVP & Chief Business Officer
• Steven D Skolsky,
  Director